Dr. Vijay N. Gadhavi,
BACKGROUND In 1993, the World Bank ranked anaemia as the 8th leading cause of disease in girls and women in the developing world. Apart from maternal morbidity and mortality, neonatal mortality is high among the babies of anaemic mothers. Pregnant women are particularly considered to be the most vulnerable group because of the additional demands that are made on maternal stores. Objectives of the study are- 1) To study effects and benefits of interventions offered to patients. 2) To study the outcome of foetus in pregnant patients suffering from anaemia. 3) To screen and diagnose all the patients suffering from anaemia and give them appropriate treatment for the same and further prevention in context to public health. 4) To find out the underlying causes and factors associated with anaemia and assess the awareness in the patients regarding these causes. MATERIALS AND METHODS This study involved total of 300 antenatal anaemic booked patients in group A treated with haematinics, iron sucrose injections and folic acid supplementation. Group B contains unbooked patients who came to emergency department, corrected their anaemia level with blood transfusion. RESULTS Booked patients detected early to be anaemic and treated with inj. iron sucrose and inj. Vit B12 and folic acid have better prognosis with better foetal and maternal outcome. Patients who came to the emergency department and who were given blood transfusion to combat anaemia had maximum preterm labour, eclampsia, PPH and sepsis.
